TABLE 3.
KEGG enrichment analyses results.
| KEGG ID | Description | Number | P value | Q value |
| ko04668 | TNF signaling pathway | 16 | 4.09E-08 | 1.39E-06 |
| ko04064 | NF-kappa B signaling pathway | 19 | 1.94E-07 | 5.11E-06 |
| ko04216 | Ferroptosis | 11 | 9.06E-09 | 3.58E-07 |
| ko04217 | Necroptosis | 24 | 8.24E-12 | 9.77E-10 |
| ko04621 | NOD-like receptor signaling pathway | 27 | 2.20E-13 | 5.22E-11 |
| ko04380 | Osteoclast differentiation | 20 | 2.17E-10 | 1.71E-08 |
| ko05164 | Influenza A | 22 | 1.40E-09 | 8.30E-08 |
| ko05169 | Epstein-Barr virus infection | 27 | 4.83E-09 | 2.29E-07 |
| ko05162 | Measles | 18 | 6.86E-08 | 2.03E-06 |
| ko05160 | Hepatitis C | 18 | 2.47E-07 | 5.85E-06 |
| ko04620 | Toll-like receptor signaling pathway | 13 | 4.66E-06 | 9.21E-05 |
| ko04625 | C-type lectin receptor signaling pathway | 13 | 4.66E-06 | 9.21E-05 |
| ko05145 | Toxoplasmosis | 13 | 7.74E-06 | 1.41E-04 |
| ko05321 | Inflammatiory bowel disease (IBD) | 10 | 1.31E-05 | 2.07E-04 |
| ko05167 | Kaposi sarcoma-associated herpesvirus infection | 17 | 1.31E-05 | 2.07E-04 |
| ko05134 | Legionellosis | 9 | 1.80E-05 | 2.67E-04 |
| ko04978 | Mineral absorption | 9 | 2.74E-05 | 3.82E-04 |
| ko05161 | Hepatitis B | 15 | 3.21E-05 | 4.23E-04 |
| ko04062 | Chemokine signaling pathway | 16 | 6.01E-05 | 7.50E-04 |
| ko04920 | Adipocytokine signaling pathway | 9 | 8.36E-05 | 9.90E-04 |